Cascadian Therapeutics, Inc. Shareholders' Equity
Cascadian Therapeutics, Inc. had Shareholders' Equity of $109.04 million as of 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2018-03-08
- 2017-12-31: Stockholders' Equity Attributable to Parent $109.04M.
- 2017-09-30: Stockholders' Equity Attributable to Parent $124.62M.
- 2017-06-30: Stockholders' Equity Attributable to Parent $137.91M.
- 2017-03-31: Stockholders' Equity Attributable to Parent $151.69M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2017-12-31 | $109.04M 10-K · filed 2018-03-08 | |
| 2017-09-30 | $124.62M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $137.91M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $151.69M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $74.36M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $84.30M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $94.31M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $73.75M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $83.73M 10-K · filed 2018-03-08 | |
| 2015-09-30 | $92.06M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $96.11M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $106.28M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $91.27M 10-K · filed 2018-03-08 | |
| 2014-09-30 | $118.40M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $57.25M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $62.69M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $71.55M 10-K · filed 2017-03-09 | |
| 2013-09-30 | $72.51M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $68.50M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $74.50M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $82.32M 10-K · filed 2016-03-14 | |
| 2012-09-30 | $77.47M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $85.73M 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $43.48M 10-Q/A · filed 2012-08-13 | |
| 2011-12-31 | $33.43M 10-K · filed 2015-03-10 | |
| 2011-09-30 | $35.76M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $21.65M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $18.86M 10-K · filed 2013-03-14 | |
| 2009-12-31 | $18.86M 10-K · filed 2014-03-13 | $25.42M 10-K/A · filed 2012-08-13 |
| 2008-12-31 | $20.65M 10-K/A · filed 2012-08-13 |